Bookmark and Share

Michael D. Chuong
View Curriculum Vitae 

Michael D. Chuong M.D.

Academic Title: Assistant Professor
Primary Appointment: Radiation Oncology
Location: Gudelksy, GGJ-84
Phone: 410-328-6080
Fax: 410-328-6911

Personal History:

Dr. Chuong is a native of Florida. He completed his undergraduate degree at Brandeis University in Waltham, MA and then attended the University of South Florida College of Medicine in Tampa, FL. He completed radiation oncology residency training at the H. Lee Moffitt Cancer Center where he also served a chief resident.

Research Interests:

Dr. Chuong's research centers around use of advanced radiation techniques for the treatment gastrointestinal cancers. This includes the use of low dose fractionated radiation therapy as a chemopotentiator, stereotactic body radiation therapy, and proton therapy. Furthermore, his research also involves the combination of radiation therapy with novel systemic agents including immunotherapy. Dr. Chuong is the principal investigator of several clinical trials at the University of Maryland and is actively involved in clinical trial design as well as translational research.

Clinical Specialty:

Dr. Chuong's primary focus is using radiation therapy to treat gastrointestinal cancers and lymphomas. He is proficient in the use intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT), and selective internal radiation therapy (SIRT) using yttrium-90 microspheres. He also will be treating patients with proton therapy at the Maryland Proton Treatment Center in Baltimore.


Chuong MD, Frakes JM, Figura N, Hoffe SE, Shridhar R, Mellon EA, Hodul RJ, Malafa MP, Springett GM, Centeno BA. "Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer." Accepted to Journal of Gastrointestinal Oncology, 2015 June 17.

Mellon E, Hoffe S, Springett G, Frakes J, Hodul P, Malafa M, Strom T, Chuong M, Shridhar R. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma. Acta Oncologica, 2015 Mar 3:1-7.

Chuong MD, Mehta MP, Langen K, Regine WF. Is proton beam therapy better than standard radiation therapy? The available evidence points to benefits of proton beam therapy. Clin Adv Hematol Oncol. 2014 Dec;12(12):861-4.

Lin J, Kligerman S, Goel R, Sajedi P, Suntharalingam M, Chuong MD. State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment. Journal of Gastrointestinal Oncology, 2014 Jul 02. doi:10.3978/j.issn.2078-6891.2014.062.

Chuong MD, Boggs DH, Patel KN, Regine WF. Adjuvant chemoradiation for pancreatic cancer: What does the evidence tell us? Journal of Gastrointestinal Oncology, 2014 May 08. doi:10.3978/j.issn.2078-6891.2014.025.

Chuong MD, Springett GM, Freilich JM, Park CK, Weber JM, Mellon EA, Hodul PJ, Malafa MP, Meredith KL, Hoffe SE, Shridhar R. Stereotactic Body Radiation Therapy (SBRT) For Borderline Resectable and Locally Advanced Pancreatic Cancer Is Effective And Well-Tolerated. International Journal of Radiation Oncology Biology Physics, 2013 July 1;86(3):516-22. doi:10.1016/j.ijrobp.2013.02.022. Epub 2013 April 5.

Rao NG, Han G, Greene JN, Tanvetyanon T, Kish JA, De Conti RC, Chuong MD, Shridhar R, Biagioli, Caudell JJ, Trotti AM. Effect of prophylactic fluconazole on oral mucositis and candidiasis during radiation therapy for head-and-neck cancer. Pract Radiat Oncol. 2013 Jul-Sep;3(3):229-33. doi: 10.1016/j.prro.2012.05.008. Epub 2012 Jun 21.

Chuong MD, Fernandez DF, Shridhar R, Hoffe SE, Saini A, Hunt D, Meredith KL, Biagioli MC. HDR Endorectal Brachytherapy for Locally Advanced Rectal Cancer in Previously Irradiated Patients. Brachytherapy. 2013 May 23. doi:pii:S1538-4721(13)00228-6. 10.1016/j.brachy.2012.11.003. [Epub ahead of print].

Shridhar R, Almhanna K, Hoffe SE, Fulp W, Weber J, Chuong MD, Meredith KL. Increased Survival Associated with Surgery and Radiation Therapy in Metastatic Gastric Cancer: A SEER Database Analysis. Cancer. 2013 May 1;119(9):1636-42. doi: 10.1002/cncr.27927. Epub 2013 Jan 29.

Shridhar R, Hoffe SE, Almhanna K, Weber JM, Chuong MD, Karl RC, Meredith K. Lymph Node Harvest in Esophageal Cancer After Neoadjuvant Chemoradiotherapy. Annals of Surgical Oncology. 2013 April 28. [Epub ahead of print].

Shridhar R, Biagioli MC, Chuong MD, Cruz A, Hoffe SE. Radiation therapy and esophageal cancer. Cancer Control; 2013 Apr,20(2):97-110.

Chuong MD, Freilich JM, Weber JM, Almhanna K, Meredith KL, Biagioli MC, Hoffe SE, Shridhar R. Intensity-Moduled Radiation Therapy Versus Conventional Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal. Gastrointestinal Cancer Research. 2013 Mar;6(2):39-45.

Harris ER, Freilich J, Lin H, Chuong M, Acs G. The Impact of the Size of Nodal Metastases on Recurrence Risk in Breast Cancer Patients with One to Three Positive Nodes Post-mastectomy. International Journal of Radiation Oncology Biology Physics, 2013 Mar 1;85(3):609-614. doi. 10.1016/j.ijrobp.2012.05.050. Epub 2012 Aug 3.

Cruz A, Chuong MD, Shridhar R, Hoffe SE. What is the role of radiation therapy in treating liver tumors? Clinical Practice. 2012 Nov;9(6):683-699. doi: 10.2217/cpr.12.64.

Chuong MD, Springett GM, Weber JM, Klapman J, Vignesh S, Hodul PJ, Malafa MP, Leuthold S, Hoffe SE, Shridhar R. Induction gemcitabine-based chemotherapy and neoadjuvant stereotactic body radiation therapy achieve high margin-negative resection rates for borderline¿resectable pancreatic cancer. Journal of Radiation Oncology. 2012;1(3):273-281. doi:10.1007/s13566-012-0039-6.

Chuong MD, Hoffe SE, Weber J, Freilich JM, Lomas H, Almhanna K, Dessureault S, Dinwoodie W, Kim R, Meredith K, Strosberg J, Shibata D, Rao NG, Biagioli MC, Shridhar R. Outcomes of anal cancer treated with definitive IMRT-based chemoradiation. Journal of Radiation Oncology. 2012;1(2):165-172. doi: 10.1007/s13566-012-0029-8.

Shridhar R, Hayman T, Hoffe SE, Weber J, Almhanna K, Chuong M, Karl RC, Meredith KL. Body Mass Index and Survival in Esophageal Adenocarcinoma Treated with Chemoradiotherapy Followed by Esophagectomy, Journal of Gastrointestinal Surgery. 2012;16(7):1296-1302.

Rao NG, Han G, Greene JN, Tanvetyanon T, Kish JA, DeConti RC, Shridhar R, Biagioli MC, Chuong MD, Caudell JJ, Trotti A. Effect of Prophylactic Fluconazole on Oral Mucositis and Cadidiasis During Radiotherapy for Head and Neck Cancer. Practical Radiation Oncology.2012;doi: 10.1016/j.prro.2012.05.008.

Lomas H, Hoffe SE, Weber J, Dilling TJ, Chuong MD, Almhanna MD, Meredith KL, Shridhar R. Post Chemoradiation PET SUV is Highly Predictive of Overall Survival in Esophageal Cancer. Journal of Nuclear Medicine and Radiation Therapy. 2012;3:125. doi:10.4172/2155-9619.1000125.

Chuong MD, Hayman TJ, Patel M, Russell MS, Malafa MP, Hodul PJ, Springett GM, Choi J, Shridhar R, Hoffe SE. Comparison of 1-, 2-, and 3-Dimensional Tumor Response Assessment After Neoadjuvant GTX-RT in Borderline-Resectable Pancreatic Cancer. Gastrointestinal Cancer Research. 2011;4(4):122-127.